Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03006172 |
|---|---|
| Brief Title: | To Evaluate the Safety, Tolerability, and Pharmacokinetics of Inavolisib Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer |
| First Submitted : | December 22, 2016 |
| First Submitted that Met QC Criteria : | December 27, 2016 |
| First Posted : | December 30, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | March 27, 2024 |
| Last Update Posted : | March 28, 2024 |